Aggregator

Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia

3 weeks 1 day ago

The Urocross Expander System is designed to remodel the obstructing prostatic lobes during the six-month indwell time and is intentionally retrieved, leaving no permanent foreign material behind.

The post Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia appeared first on MedTech Intelligence.

Rich West

Evereden Enters U.S. Sephora Stores

3 weeks 2 days ago

The brand debuts with 12 stock keeping units across skin care, hair care, fragrance and sun care, marking its first U.S. retailer partnership.

Kathryn Hopkins